July 16, 2012
/PRNewswire-Asia/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading developer and provider of vaccines in
, announced today that it will hold its 2012 Annual Meeting of Shareholders on
Wednesday, August 22, 2012
Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi Road, Haidian District,
, PRC and at No. 6 Temple Street,
. All shareholders of record as of
July 5, 2012
will be eligible to vote and are invited to attend.
The primary agenda of the meeting is to approve the re-election of
Yuk Lam Lo
as the Company's directors until the next annual meeting of shareholders and or until their successors are duly elected; approve the audited consolidated financial statements of the Company for the financial year ended
December 31, 2011
together with the Report of Independent Registered Public Accounting Firm thereon and the notes thereto; approve the appointment of Ernst & Young LLP as the independent auditor of the Company for the fiscal year ending
December 31, 2012
and to authorize the directors of the Company to fix such independent auditor's remuneration; approve the Sinovac Biotech Ltd. 2012 Share Incentive Plan and the authorization for the issuance of 4,000,000 common shares under such plan; and approve the amendment to Section 7.5 of the Company's by-laws in order to lower the quorum of shareholders' meetings from 50%half to 33 1/3% one-third percent of common shares outstanding.
Sinovac's 2011 annual report and proxy statements, including the Notice of the 2012 Annual General Meeting, are available on the Company's website:
Shareholders of the Company may receive a hard copy of 20-F free of charge upon request. Such request can be made by sending an e-mail to
, along with complete contact details and a mailing address.